NWRNClinical Trials•businesswire•
Newron Notes the Publication of New Preclinical Research Suggesting Evenamide Ameliorates Schizophrenia-Related Dysfunction
Sentiment:Positive (65)
Summary
MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $NWRN #schizophrenia--New findings in Neuropsychopharmacology - first to demonstrate that evenamide targets the key site of schizophrenia pathology in the hippocampus.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 11, 2025 by businesswire